Lactoferrin Market to Reach US$ 511.8 Mn by 2030

The global Lactoferrin market is expected to grow at a CAGR of around 12.2% over the forecast period 2021 to 2030 and expected to reach the market value of around US$ 511.8 million by 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38450

Growth Factors

Increasing incorporation of lactoferrin in various products ranges including infant food, food supplements, dietetic foods, alcoholic beverages, sports nutrition, and personal care and cosmetics should bolster lactoferrin market in the forecast timeframe, ascribed to strong health benefits.

Lactoferrin offers stimulating effects on immune system, prevents cell damage caused by aging, promotes culture of beneficial bacterial in the intestinal tract, and regulates viruses, bacteria and fungi along with being regulator to iron metabolism. Lactoferrin is found effective for the treatment of hepatitis C infection by inhibiting replication of the virus at intracellular level. Hence, strong applicability of lactoferrin in nutraceutical, pharmaceutical, and personal care industries is anticipated to drive demand during the forecast period. 

Report Highlights

The iron absorption segment accounted for the highest revenue share of more than 39% in 2020 and is expected to maintain its leading position over the forecast period. Iron deficiency usually leads to anemia, which roughly affects over 40% of the global population. Lactoferrin has been a crucial solution for anemia, its high level of bioavailability along with the ability to increase serum ferritin levels by five times allows efficient absorption of iron when compared to other iron sources.

The infant formula segment held the highest revenue share of more than 48% in 2020 and will expand further at a steady CAGR from 2021 to 2030. The demand is anticipated to grow owing to the increase in the number of clinical studies supporting infant formula integration with lactoferrin and changing consumer dynamics towards infant supplementary foods. The demand for infant nutrition is majorly from the developed economies owing to the significant disposable income, busy work schedules, and rising incidences of iron deficiency among infants.

Asia Pacific emerged as the largest regional market in 2020 with a revenue share of more than 52%. The regional market is expected to maintain its position throughout the forecast period. Led by India, China, and Japan, the regional market growth can be attributed to the growing population and rising spending capacity of the consumers. Asia Pacific, unlike most other regions, has a sizable number of medium and small businesses. Moreover, with increasing literacy rate and rising consumer awareness regarding infant nutrition, personal care, and pharmaceutical products along with consumer inclination toward organic products are expected to drive the market growth.

Key Players

  • Hilmar Cheese Company
  • Pharming Group NV
  • FrieslandCampina
  • Synlait Milk Ltd.
  • Ingredia SA
  • MP Biomedicals
  • Tatura Milk Industries Ltd.
  • Glanbia plc
  • APS BioGroup
  • ProHealth
  • Fonterra Cooperative Group Ltd.
  • Farbest Brands
  • InVitria
  • Milei GmbH
  • Ferrin-tech LLC
Report Coverage Details
Market Size US$ 511.8 million by 2030
Growth Rate CAGR of 12.2% From 2021 to 2030
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Function, Application
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Hilmar Cheese Company; Pharming Group NV; FrieslandCampina; Synlait Milk Ltd.; Ingredia SA; MP Biomedicals; Tatura Milk Industries Ltd.; Glanbia plc; APS BioGroup; ProHealth; Fonterra Cooperative Group Ltd.; Farbest Brands; InVitria; Milei GmbH; Ferrin-tech LLC

Market Segmentation

  • Function
    • Iron Absorption
    • Anti-inflammatory
    • Intestinal Flora Protection
    • Antibacterial
    • Immune Cell Stimulation
    • Antioxidant
  • Application
    • Food & Beverages
    • Infant Formula
    • Sports & Functional Foods
    • Pharmaceuticals
    • Personal Care Products
    • Animal Feed
  • Regional
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • U.K.
      • France
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
    • Central & South America
      • Brazil
    • Middle East & Africa
      • UAE

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38450

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Lactoferrin Market, By Function

7.1.  Lactoferrin Market, by Function, 2021-2030

7.1.1.    Iron Absorption

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Anti-inflammatory

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Intestinal Flora Protection

7.1.3.1.        Market Revenue and Forecast (2017-2030)

7.1.4.    Antibacterial

7.1.4.1.        Market Revenue and Forecast (2017-2030)

7.1.5.    Immune Cell Stimulation

7.1.5.1.        Market Revenue and Forecast (2017-2030)

7.1.6.    Antioxidant

7.1.6.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Lactoferrin Market, By Application

8.1.  Lactoferrin Market, by Application, 2021-2030

8.1.1.    Food & Beverages

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Infant Formula

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Sports & Functional Foods

8.1.3.1.        Market Revenue and Forecast (2017-2030)

8.1.4.    Pharmaceuticals

8.1.4.1.        Market Revenue and Forecast (2017-2030)

8.1.5.    Personal Care Products

8.1.5.1.        Market Revenue and Forecast (2017-2030)

8.1.6.    Animal Feed

8.1.6.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Lactoferrin Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, by Function (2017-2030)

9.1.2.    Market Revenue and Forecast, by Application (2017-2030)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, by Function (2017-2030)

9.1.3.2.        Market Revenue and Forecast, by Application (2017-2030)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, by Function (2017-2030)

9.1.4.2.        Market Revenue and Forecast, by Application (2017-2030)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, by Function (2017-2030)

9.2.2.    Market Revenue and Forecast, by Application (2017-2030)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, by Function (2017-2030)

9.2.3.2.        Market Revenue and Forecast, by Application (2017-2030)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, by Function (2017-2030)

9.2.4.2.        Market Revenue and Forecast, by Application (2017-2030)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, by Function (2017-2030)

9.2.5.2.        Market Revenue and Forecast, by Application (2017-2030)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, by Function (2017-2030)

9.2.6.2.        Market Revenue and Forecast, by Application (2017-2030)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, by Function (2017-2030)

9.3.2.    Market Revenue and Forecast, by Application (2017-2030)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, by Function (2017-2030)

9.3.3.2.        Market Revenue and Forecast, by Application (2017-2030)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, by Function (2017-2030)

9.3.4.2.        Market Revenue and Forecast, by Application (2017-2030)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, by Function (2017-2030)

9.3.5.2.        Market Revenue and Forecast, by Application (2017-2030)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, by Function (2017-2030)

9.3.6.2.        Market Revenue and Forecast, by Application (2017-2030)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, by Function (2017-2030)

9.4.2.    Market Revenue and Forecast, by Application (2017-2030)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, by Function (2017-2030)

9.4.3.2.        Market Revenue and Forecast, by Application (2017-2030)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, by Function (2017-2030)

9.4.4.2.        Market Revenue and Forecast, by Application (2017-2030)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, by Function (2017-2030)

9.4.5.2.        Market Revenue and Forecast, by Application (2017-2030)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, by Function (2017-2030)

9.4.6.2.        Market Revenue and Forecast, by Application (2017-2030)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, by Function (2017-2030)

9.5.2.    Market Revenue and Forecast, by Application (2017-2030)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, by Function (2017-2030)

9.5.3.2.        Market Revenue and Forecast, by Application (2017-2030)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, by Function (2017-2030)

9.5.4.2.        Market Revenue and Forecast, by Application (2017-2030)

Chapter 10.  Company Profiles

10.1.              Hilmar Cheese Company

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              Pharming Group NV

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              FrieslandCampina

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Synlait Milk Ltd.

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Ingredia SA

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              MP Biomedicals

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              Tatura Milk Industries Ltd.

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Glanbia plc

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              APS BioGroup

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.           ProHealth

10.10.1.               Company Overview

10.10.2.               Product Offerings

10.10.3.               Financial Performance

10.10.4.               Recent Initiatives

10.11.           Fonterra Cooperative Group Ltd.

10.11.1.               Company Overview

10.11.2.               Product Offerings

10.11.3.               Financial Performance

10.11.4.               Recent Initiatives

10.12.           Farbest Brands

10.12.1.               Company Overview

10.12.2.               Product Offerings

10.12.3.               Financial Performance

10.12.4.               Recent Initiatives

10.13.           InVitria

10.13.1.               Company Overview

10.13.2.               Product Offerings

10.13.3.               Financial Performance

10.13.4.               Recent Initiatives

10.14.           Milei GmbH

10.14.1.               Company Overview

10.14.2.               Product Offerings

10.14.3.               Financial Performance

10.14.4.               Recent Initiatives

10.15.           Ferrin-tech LLC

10.15.1.               Company Overview

10.15.2.               Product Offerings

10.15.3.               Financial Performance

10.15.4.               Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38450

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com